신경 재활 기기 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Neurorehabilitation Devices Market size is expected to reach USD 9.18 Billion in 2034 from USD 2.74 Billion (2025) growing at a CAGR of 14.36% during 2026-2034.

The neurorehabilitation devices market is witnessing significant growth due to the rising prevalence of stroke, spinal cord injuries, and neurodegenerative disorders. Improvements in emergency care have increased survival rates, creating greater demand for long-term rehabilitation solutions. Technological advancements in robotics, wearable devices, and brain stimulation systems are transforming traditional therapy methods. Healthcare providers are increasingly adopting device-assisted rehabilitation to enhance recovery outcomes and improve patient mobility.

Key drivers include the growing elderly population and increased awareness about early rehabilitation benefits. Robotic-assisted therapy and virtual reality-based systems allow repetitive, controlled movements that improve neurological recovery. Rising healthcare expenditure and government initiatives supporting rehabilitation infrastructure are also fueling growth. Additionally, tele-rehabilitation solutions are expanding access to therapy services in remote and underserved regions.

Looking forward, integration of artificial intelligence and data analytics into rehabilitation devices is expected to personalize therapy programs and improve efficiency. The market will likely expand as cost-effective wearable technologies become more accessible. Companies focusing on clinical validation and patient-centric designs will play a critical role in shaping the future of neurorehabilitation care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Neurorobotics
• Brain-Computer Interface
• Wearable Devices
• Non-Invasive Stimulators
• Others

By Therapy Area

• Stroke
• Parkinson's Disease
• Multiple Sclerosis
• Cerebral Palsy
• Others

COMPANIES PROFILED

• Bioventus, Ectron, Hocoma, Medtronic, Tyromotion Inc, Biometrics Ltd, Bionik Laboratories Corp BNKL, BioXtreme Ltd, Ekso Bionics, Kinestica, Kinova Inc, Saebo Inc, Abbott
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Neurorobotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Brain-Computer Interface Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Wearable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Non-Invasive Stimulators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY THERAPY AREA 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy Area
• 5.2. Stroke Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Parkinson's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Multiple Sclerosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Cerebral Palsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEUROREHABILITATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By Therapy Area
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By Therapy Area
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By Therapy Area
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By Therapy Area
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By Therapy Area
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEUROREHABILITATION DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Bioventus
  • 8.2.2 Ectron
  • 8.2.3 Hocoma
  • 8.2.4 Medtronic
  • 8.2.5 Tyromotion Inc
  • 8.2.6 Biometrics Ltd
  • 8.2.7 Bionik Laboratories Corp. (BNKL)
  • 8.2.8 BioXtreme Ltd
  • 8.2.9 Ekso Bionics
  • 8.2.10 Kinestica
  • 8.2.11 Kinova Inc
  • 8.2.12 Saebo Inc
  • 8.2.13 Abbott